FDA qualification of Total Hip BMD as a validated surrogate endpoint for novel osteoporosis drug development further bolsters Entera's July 2025 FDA alignment and regulatory strategy for EB613 ... .
MARKET > NEWS. BMDGoldFutures End Lower On Profit-taking ... KUALA LUMPUR, Oct 2 (Bernama) -- Gold futures on Bursa Malaysia Derivatives (BMD) ended lower today on profit-taking ... ....